600789.SS
600789.SS
CNE000000P61
SHANDONG LUKANG PHARMACEUTICAL
Loading chart...

Company Profile

Shandong Lukang Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in China. The company offers systemic anti-infectives, hypoglycemic agents, cardiovascular and cerebrovascular drugs, respiratory medicines, neurodegenerative disease treatments, digestive and metabolic disease drugs, antitumor drugs, and traditional Chinese and Tibetan medicines. The company also provides synthetic biology products, including trans-aconitic acid, perillyl alcohol, bisabolol, and patchouli alcohol, and engages in the production and sale of feed additives and import-export trade; and ceftriaxone sodium, acetylspiramycin, amoxicillin, tadalafil tablets, acarbose, rosuvastatin, isosorbide mononitrate sustained-release tablets, and various veterinary antibiotics and preparations. In addition, the company engages in hazardous waste treatment, environmental protection engineering, equipment installation and maintenance, and production and sale of biological pesticides. The company was formerly known as Jining Antibiotic Factory and changed its name to Shandong Lukang Pharmaceutical Co.,Ltd. in October 1993. Shandong Lukang Pharmaceutical Co.,Ltd. was founded in 1966 and is headquartered in Jining, China.

Related stocks

002332.SZ
002332.SZ • China
XJZY
8.76 CNY
1.3B USD 1Y -11.2%
600993.SS
600993.SS • China
MAYINGLONG PHARMACEUTICAL GP CO
22.95 CNY
1.48B USD 1Y -15%
301263.SZ
301263.SZ • China
TEK
19.14 CNY
1.22B USD 1Y -31.8%
600129.SS
600129.SS • China
CHONGQING TAIJI IND
13.97 CNY
1.15B USD 1Y -36.3%
600812.SS
600812.SS • China
NORTH CHINA PHARMACEUTICAL CO
6.03 CNY
1.55B USD 1Y +1.5%
002349.SZ
002349.SZ • China
JINGHUA PHARM
9.24 CNY
1.15B USD 1Y +28.3%
002275.SZ
002275.SZ • China
GLSJ
12.35 CNY
1.09B USD 1Y -16%
300702.SZ
300702.SZ • China
TIANYU PHARMA
22.18 CNY
1.15B USD 1Y -13.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
37.2% p.a.
Max Drawdown (5Y)
-42.2%
Sharpe Ratio (5Y)
0.02
Beta Factor
0.23
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 63.7 (Elevated multiple compression risk)
Elevated Short-Term Volatility: 3Y volatility (42.0%) is noticeably higher than the 5Y average (37.2%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (37.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -69.0% in the extended horizon.
ende